Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed May 18, 2020 · 10-Q · 48 days after period end · 0001654954-20-005714
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $11.10K | $206.00 | $91.17K | $0.00 |
| Net Income | -$94.26K | -$202.54K | -$265.64K | -$195.70K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 18, 2020 · 48 d after period end
